When advisors make recommendations to drug coverage it's often based on an employers rising costs. Many times, the effect of a claim is measured on an employee's current claim (and their family) and how they are affected. What is left out is the effect on the NEXT employee that may not have coverage. Hilary will share her journey and the many challenges along the way....
Organizations and how they function continue to evolve. Consequently, expectations of external vendors like Group Benefits Advisors are greater then ever before. Relationships with your clients (and potential clients) are no longer an original sale, periodic updates, and annual renewals process. It requires leadership, relationship, education, governance, and everything in between. Accepting of this is crucial, knowing what that means specific to you and your clients is paramount.
Gord and Gavin will discuss the rise of Creative Plan designs now available. They will discuss the pros and cons of; newer disability products like ASID and others, exclusionary drug formularies, drug plan maximums, hybrid benefit plans (like CHIP), optional individual plans and more. We have a lot of new and unique solutions to help address problems that we seldom saw 10 - 20 years ago. The need for good advice and problem solving by advisors has never been needed more, and now we have the tools to do just that.
National Pharmacare, National Dental Program, Increasing LTD rates, EI changes, more high cost drugs, gene therapies, what else is on the horizon?
Are you communicating with employees on these issues? Do you have solutions available to resolve them when asked?
We'll take a look both back and forward, and discuss what you might want to do to be prepared.